Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Chinese herbals

This article was originally published in The Tan Sheet

Executive Summary

FDA says its Office of Regulatory Affairs is working with the agency's Los Angeles district office to investigate the presence of the diabetes drugs glyburide and phenformin found in five Chinese herbals sold by Sino American Health Products and Chinese Angel Health Products. The California Department of Health posted a public health warning about the products Feb. 15 (1"The Tan Sheet" Feb. 21, p. 9). Both firms have issued press releases alerting consumers about the items and recall actions have been initiated. FDA also has issued "automatic detention" import alerts 66-10 and 66-41 notifying U.S. Customs and postal service officials about the products

You may also be interested in...

Five Chinese Herbals Contain Drug Ingredients, Calif. Health Dept. Warns

The California Department of Health Services' Food & Drug branch posted a public health warning Feb. 15 notifying consumers that five Chinese herbal products contain the prescription diabetes drugs glyburide and phenformin.

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts